Ad-hoc-announcement

01 February 2012	WILEX AG successfully completes rights issue
09 January 2012	WILEX AG resolves rights issue using authorised capital
21 November 2011	WILEX AG: ARISER Independent Data Monitoring Committee (IDMC) recommends conducting the final analysis of the pivotal Phase III trial with RENCAREX^®
14 October 2011	WILEX reports an adjustment of the goodwill of Heidelberg Pharma AG according to IFRS

Archive

Seite gelesen: 1803 | Heute: 13